🇺🇸 FDA
Patent

US 6512091

Genetic Markers for breast, ovarian, and prostatic cancer

expired A61KA61K48/00

Quick answer

US patent 6512091 (Genetic Markers for breast, ovarian, and prostatic cancer) held by The Regents of the University of California expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K48/00